San Francisco, United States
Predictiv Care 🧬, founded in 2020, is a noteworthy player in the Biotechnology and Health Care industries, headquartered in the United States. This innovative company is making waves with its personal genomics solution focused on predictive medicine. Utilizing a unique and groundbreaking technology, Predictiv Care identifies genetic predispositions for over 22,000 diseases and simulates reactions to more than 750 drugs.
The company’s offering—a DNA-based Digital Twin—enables more accurate preventive actions and treatments, aligning with the growing trend towards personalized medicine. This capability not only sets the stage for improving health outcomes but also positions the company as a potential leader in this niche market.
Their most recent financial milestone was a Seed Round investment on 17 August 2022, with backing from Naver D2 Startup Factory. This early-stage investment underscores investor confidence and provides a solid foundation for future growth and development.
